Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

29. Juli 2025 08:00 ET | Quelle: Cingulate Inc.

Cingulate Receives $4.3M Waiver from FDA Ahead of Imminent Filing for Marketing Approval of Lead ADHD Asset CTx-1301

KANSAS CITY, Kan., July 29, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
02. August 2022 10:00 ET | Quelle: Novel Capital

B2B Revenue Growth Platform Novel Capital Hires First Chief Credit Officer

KANSAS CITY, Mo., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Novel Capital, the fintech Revenue Growth Platform that helps B2B businesses accelerate their growth, announced that it has hired a new Chief...
17. März 2022 10:00 ET | Quelle: Novel Capital

Revenue-Based Financing Platform, Novel Capital, Announces $115M in Funding to Transform How Companies with Predictable Revenue Fund Their Growth

KANSAS CITY, Mo., March 17, 2022 (GLOBE NEWSWIRE) -- Novel Capital, a fintech company helping businesses accelerate growth, came out of stealth today with $115M in initial equity and debt funding....